Lista de obras - Patrice Viens - Dominio Público Uruguay

A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

artículo científico publicado en 2017

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor

artículo científico publicado en 2015

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

artículo científico publicado en 2013

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

artículo científico publicado en 2009

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

artículo científico publicado en 2012

Assessment of prognostic scores in brain metastases from breast cancer.

artículo científico publicado en 2013

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

artículo científico publicado en 2012

BetaHCG secretion by a pulmonary adenocarcinoma.

scientific article published on 14 September 2013

Bevacizumab in HER2-negative inflammatory breast cancer

artículo científico publicado en 2016

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

artículo científico publicado en 2016

Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.

artículo científico publicado en 2012

Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling

artículo científico publicado en 2014

Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

artículo científico publicado en 2014

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

artículo científico publicado en 2018

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

artículo científico publicado en 2017

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

artículo científico publicado en 2014

Clinical development of mTOR inhibitors in breast cancer

artículo científico publicado en 2014

Comparative genomic analysis of primary tumors and metastases in breast cancer.

artículo científico publicado en 2016

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer

artículo científico publicado en 2013

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

artículo científico publicado en 2016

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

scientific article published on 08 June 2011

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

article

Difference in therapeutic response between basal and nonbasal triple-negative breast cancers.

artículo científico publicado en 2013

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

artículo científico publicado en 2012

Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients.

artículo científico publicado en 2011

EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer

artículo científico publicado en 2014

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival

scientific article published on 02 December 2013

Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.

artículo científico publicado en 2011

Genomic and expression analysis of microdissected inflammatory breast cancer

artículo científico publicado en 2013

Genomic profiling of inflammatory breast cancer: a review.

artículo científico publicado en 2014

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.

artículo científico publicado en 2016

High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes

artículo científico publicado en 2011

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2016

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2017

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

artículo científico publicado en 2016

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

artículo científico publicado en 2015

Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience

artículo científico publicado en 2017

Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.

artículo científico publicado en 2010

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

artículo científico publicado en 2010

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

artículo científico publicado en 2016

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

artículo científico publicado en 2010

MARCKS protein overexpression in inflammatory breast cancer

artículo científico publicado en 2016

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.

artículo científico publicado en 2016

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.

artículo científico publicado en 2017

Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

artículo científico publicado en 2012

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

artículo científico publicado en 2016

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

artículo científico publicado en 2012

Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106).

artículo científico publicado en 2017

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

artículo científico publicado en 2016

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer

artículo científico publicado en 2015

Participants' uptake of clinical trial results: a randomised experiment.

artículo científico publicado en 2010

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

artículo científico publicado en 2014

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

artículo científico publicado en 2011

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation

artículo científico publicado en 2010

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

artículo científico publicado en 2010

Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer

artículo científico publicado en 2010

Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

artículo científico publicado en 2009

Prognostic and predictive value of PDL1 expression in breast cancer

artículo científico publicado en 2015

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

artículo científico publicado en 2015

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

artículo científico publicado en 2016

Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review.

artículo científico publicado en 2013

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

scientific article published on 04 July 2011

Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.

artículo científico publicado en 2010

SPAG5: the ultimate marker of proliferation in early breast cancer?

artículo científico publicado en 2016

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

artículo científico publicado en 2017

Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer

artículo científico publicado en 2017

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.

artículo científico publicado en 2017

Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective

artículo científico publicado en 2017

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

scientific article published on 06 May 2019

Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience.

artículo científico publicado en 2010

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

scientific article published on 18 October 2016

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

artículo científico publicado en 2018

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

artículo científico

Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma

artículo científico publicado en 2015

Transparency in the presentation of trial results may not increase patients' trust in medical researchers.

artículo científico publicado en 2011

Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer

artículo científico publicado en 2012

UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.

artículo científico

Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets

artículo científico publicado en 2013

Young breast cancer patients' involvement in treatment decisions: the major role played by decision-making about surgery.

artículo científico publicado en 2013

[Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]

artículo científico publicado en 2011

[Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers]

artículo científico publicado en 2010

[Systemic treatments of inflammatory breast cancer: an overview].

artículo científico publicado en 2014

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

artículo científico publicado en 2013

Lista de obras de Patrice Viens

A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Assessment of prognostic scores in brain metastases from breast cancer.

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

BetaHCG secretion by a pulmonary adenocarcinoma.

Bevacizumab in HER2-negative inflammatory breast cancer

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.

Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling

Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

Clinical development of mTOR inhibitors in breast cancer

Comparative genomic analysis of primary tumors and metastases in breast cancer.

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

Difference in therapeutic response between basal and nonbasal triple-negative breast cancers.

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients.

EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival

Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.

Genomic and expression analysis of microdissected inflammatory breast cancer

Genomic profiling of inflammatory breast cancer: a review.

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.

High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience

Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

MARCKS protein overexpression in inflammatory breast cancer

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.

Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106).

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer

Participants' uptake of clinical trial results: a randomised experiment.

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer

Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

Prognostic and predictive value of PDL1 expression in breast cancer

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review.

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.

SPAG5: the ultimate marker of proliferation in early breast cancer?

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.

Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience.

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma

Transparency in the presentation of trial results may not increase patients' trust in medical researchers.

Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer

UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.

Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets

Young breast cancer patients' involvement in treatment decisions: the major role played by decision-making about surgery.